BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22460220)

  • 1. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy.
    Ishihara S; Yashima K; Kushiyama Y; Izumi A; Kawashima K; Fujishiro H; Kojo H; Komazawa Y; Hamamoto T; Yamamoto T; Sasaki Y; Shimizu T; Okamoto E; Yoshimura T; Furuta K; Noguchi N; Tanaka H; Murawaki Y; Kinoshita Y
    J Gastroenterol; 2012 Oct; 47(10):1084-90. PubMed ID: 22460220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Organic Colonic Lesions by Colonoscopy in Patients with Irritable Bowel Syndrome Fulfilling Rome III Criteria.
    Sarkar MM; Saha M; Saha BN; Chowdhury MK; Hasan MN; Arefin MS; Tariquzzaman M
    Mymensingh Med J; 2020 Oct; 29(4):914-919. PubMed ID: 33116096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome.
    Paudel MS; Mandal AK; Shrestha B; Poudyal NS; Kc S; Chaudhary S; Shrestha R; Goel K
    JNMA J Nepal Med Assoc; 2018; 56(209):487-492. PubMed ID: 30058630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.
    Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
    Scand J Gastroenterol; 2015 Jul; 50(7):816-23. PubMed ID: 25636675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    Ono M; Kato M; Miyamoto S; Tsuda M; Mizushima T; Ono S; Nakagawa M; Mabe K; Nakagawa S; Muto S; Shimizu Y; Kudo M; Katsuki S; Meguro T; Sakamoto N
    J Gastroenterol; 2018 Aug; 53(8):916-923. PubMed ID: 29305648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic colonic lesions in patients with irritable bowel syndrome (IBS).
    Akhtar AJ; Shaheen MA; Zha J
    Med Sci Monit; 2006 Sep; 12(9):CR363-7. PubMed ID: 16940928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders.
    Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; David Tai FW; Afify S; Aziz I
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):334-341.e3. PubMed ID: 32882424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic spirochetosis is associated with colonic eosinophilia and irritable bowel syndrome in a general population in Sweden.
    Walker MM; Talley NJ; Inganäs L; Engstrand L; Jones MP; Nyhlin H; Agréus L; Kjellstrom L; Öst Å; Andreasson A
    Hum Pathol; 2015 Feb; 46(2):277-83. PubMed ID: 25540866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Rome III criteria is not likely to reduce the number of unnecessary referrals for colonoscopy in primary care.
    Kok L; Elias SG; Witteman BJ; Goedhard JG; Romberg-Camps MJ; Muris JW; Moons KG; de Wit NJ
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):568-74. PubMed ID: 23325277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study].
    Henriksen M; Høivik ML; Jelsness-Jørgensen LP; Moum B;
    J Crohns Colitis; 2018 Mar; 12(4):389-393. PubMed ID: 29186372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.
    Sood R; Camilleri M; Gracie DJ; Gold MJ; To N; Law GR; Ford AC
    Am J Gastroenterol; 2016 Oct; 111(10):1446-1454. PubMed ID: 27481310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the location of diverticular disease and the irritable bowel syndrome: a multicenter study in Japan.
    Yamada E; Inamori M; Uchida E; Tanida E; Izumi M; Takeshita K; Fujii T; Komatsu K; Hamanaka J; Maeda S; Kanesaki A; Matsuhashi N; Nakajima A
    Am J Gastroenterol; 2014 Dec; 109(12):1900-5. PubMed ID: 25331347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.
    Chey WD; Nojkov B; Rubenstein JH; Dobhan RR; Greenson JK; Cash BD
    Am J Gastroenterol; 2010 Apr; 105(4):859-65. PubMed ID: 20179696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome.
    Wong RK; Palsson OS; Turner MJ; Levy RL; Feld AD; von Korff M; Whitehead WE
    Am J Gastroenterol; 2010 Oct; 105(10):2228-34. PubMed ID: 20502449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case--control study.
    Gu HX; Zhang YL; Zhi FC; Jiang B; Huang Y
    Int J Colorectal Dis; 2011 Jul; 26(7):935-40. PubMed ID: 21374060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.